MerLion scores a first for S'pore with FDA approval of its ear infection drug
Singapore
BIOPHARMACEUTICAL company MerLion Pharmaceuticals is the first homegrown company to have its new novel drug approved by the United States Food and Drug Administration (FDA), paving the way for it to be commercially available to treat ear infections.
This follows Phase 3 trials of finafloxacin otic suspension in treating acute otitis externa, which is an infection in the outer ear and ear canal and is commonly known as "swimmer's ear".
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
Garmin’s Q1 results beat on strong demand for fitness, auto products
Foxconn’s musical chairs sound like punk rock
US sets up board to advise on safe, secure use of AI
Regulate AI? How US, EU and China are going about It
Meta’s results are best viewed through rose-tinted AI glasses